Lurbinectedin is a chemotherapy drug used to treat certain types of cancer. As with any medication, there are potential side effects that patients should be aware of.

According to the drug patent watch website [1], the most common side effects of lurbinectedin include fatigue, nausea, vomiting, constipation, decreased appetite, and low white blood cell count. Other potential side effects may include hair loss, anemia, diarrhea, and liver toxicity.

The Mayo Clinic [2] also lists similar side effects, but also notes that patients may experience an allergic reaction to the medication. Symptoms of an allergic reaction may include rash, itching, swelling, dizziness, and difficulty breathing. Patients should seek immediate medical attention if they experience any of these symptoms.

Zepzelca [3], a brand name for lurbinectedin, provides additional information about potential side effects. They note that patients may experience peripheral neuropathy, which can cause numbness, tingling, or pain in the hands and feet. Patients may also experience fatigue, fever, and dehydration.

It is important for patients to discuss potential side effects with their healthcare provider before starting treatment with lurbinectedin. They can provide additional information about what to expect and how to manage any side effects that may occur.

Sources:
[1] https://www.drugpatentwatch.com/p/tradename/LURBINECTEDIN
[2] https://www.mayoclinic.org/drugs-supplements/lurbinectedin-intravenous-route/side-effects/drg-20490804?p=1
[3] https://www.zepzelca.com/zepzelca-side-effects/